Veru Inc. (NASDAQ:VERU) Short Interest Update

Veru Inc. (NASDAQ:VERUGet Free Report) was the target of a large decline in short interest during the month of June. As of June 15th, there was short interest totalling 10,450,400 shares, a decline of 13.0% from the May 31st total of 12,010,000 shares. Based on an average trading volume of 2,642,200 shares, the days-to-cover ratio is currently 4.0 days.

Analysts Set New Price Targets

A number of research analysts have recently weighed in on VERU shares. HC Wainwright reiterated a “buy” rating and set a $3.00 price target on shares of Veru in a report on Monday, May 13th. Oppenheimer reiterated an “outperform” rating and set a $5.00 price target (down previously from $7.00) on shares of Veru in a report on Monday, April 15th. B. Riley started coverage on Veru in a report on Tuesday, May 14th. They set a “buy” rating and a $5.00 price target on the stock. Finally, Raymond James started coverage on Veru in a report on Thursday, March 28th. They set an “outperform” rating and a $3.00 price target on the stock.

Read Our Latest Stock Report on Veru

Insider Buying and Selling

In other news, CEO Mitchell Shuster Steiner sold 63,379 shares of Veru stock in a transaction on Friday, May 24th. The stock was sold at an average price of $1.23, for a total transaction of $77,956.17. Following the transaction, the chief executive officer now owns 6,942,709 shares in the company, valued at $8,539,532.07. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Insiders have sold 181,970 shares of company stock worth $250,075 in the last three months. 14.20% of the stock is currently owned by insiders.

Institutional Trading of Veru

Institutional investors have recently bought and sold shares of the company. Cetera Advisors LLC acquired a new stake in shares of Veru in the first quarter worth about $33,000. Choreo LLC acquired a new stake in shares of Veru in the first quarter worth about $64,000. 180 Wealth Advisors LLC acquired a new stake in shares of Veru in the first quarter worth about $120,000. ADAR1 Capital Management LLC acquired a new stake in shares of Veru in the fourth quarter worth about $360,000. Finally, Alpine Global Management LLC lifted its position in shares of Veru by 21.0% in the first quarter. Alpine Global Management LLC now owns 710,000 shares of the company’s stock worth $497,000 after buying an additional 122,999 shares during the last quarter. Institutional investors and hedge funds own 47.16% of the company’s stock.

Veru Trading Up 5.2 %

VERU opened at $0.84 on Friday. The stock has a market cap of $123.15 million, a price-to-earnings ratio of -2.47 and a beta of -0.39. Veru has a 1 year low of $0.36 and a 1 year high of $1.92. The stock has a fifty day moving average price of $1.15 and a 200 day moving average price of $0.83.

Veru (NASDAQ:VERUGet Free Report) last released its quarterly earnings data on Wednesday, May 8th. The company reported ($0.07) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.05) by ($0.02). The firm had revenue of $4.14 million for the quarter, compared to analyst estimates of $3.00 million. Veru had a negative net margin of 265.27% and a negative return on equity of 130.13%. As a group, sell-side analysts forecast that Veru will post -0.27 earnings per share for the current fiscal year.

About Veru

(Get Free Report)

Veru Inc, a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). Its marketed products comprise FC2 female condom for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections.

Further Reading

Receive News & Ratings for Veru Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veru and related companies with MarketBeat.com's FREE daily email newsletter.